2021
DOI: 10.1016/j.biomaterials.2021.121135
|View full text |Cite
|
Sign up to set email alerts
|

NIR-triggerable ROS-responsive cluster-bomb-like nanoplatform for enhanced tumor penetration, phototherapy efficiency and antitumor immunity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
24
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 49 publications
(24 citation statements)
references
References 49 publications
0
24
0
Order By: Relevance
“…Smart nanomedicines with high penetration-promoting properties can be classified as size-shrinkable nanoparticles, “cluster bomb”-like sequential-releasing nanoparticles, charge-reversal nanoparticles, and penetrating peptide-modified nanoparticles 27 . For instance, Shen et al devoted considerable effort to producing charge-transformable nanocarriers in response to special enzymes with high expression levels in tumor tissue, achieving high accumulation and deep tumor penetration via transcytosis effects across vascular endothelial cells and tumor cells 24 , 28 .…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…Smart nanomedicines with high penetration-promoting properties can be classified as size-shrinkable nanoparticles, “cluster bomb”-like sequential-releasing nanoparticles, charge-reversal nanoparticles, and penetrating peptide-modified nanoparticles 27 . For instance, Shen et al devoted considerable effort to producing charge-transformable nanocarriers in response to special enzymes with high expression levels in tumor tissue, achieving high accumulation and deep tumor penetration via transcytosis effects across vascular endothelial cells and tumor cells 24 , 28 .…”
Section: Introductionmentioning
confidence: 99%
“…However, endogenous stimuli affected by tumor heterogeneity might reduce the responsiveness of the nanocarriers, impeding their further application. Exogenous stimuli, such as: light, radiation, heat, and electric and magnetic fields, are more controllable and homogeneous 27 , 29 - 31 . Among them, NIR light in the “therapeutic window” (720-900 nm) is considered to be one of the most promising stimuli because of its advantages of: spatiotemporal control, deep tissue penetration, non-invasion, and safety 27 , 31 .…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…The lack of deep infiltration of tumor tissue is a major limitation of drug therapy. In addition to active targeting, Yang et al 114 for the first-time combined size-transforming and transcytosis strategies, which effectively enhanced passive diffusion and active transport to construct anti-tumor immune nanodrugs with efficient delivery efficiency (named CPIM) (Figure 20 A). In terms of passive diffusion, cluster-bomb-like nanoplatforms (135 nm) release small drug-loaded “particles” (PAMAM loaded with IR780/1- methyltryptophan (1-MT), particle size < 10 nm) under the action of high concentrations of ROS in the TME, and promote the permeation and diffusion of IR780 and 1-MT in tumor tissue.…”
Section: Pdt Combined With Other Therapiesmentioning
confidence: 99%
“…In recent years, with the increasing understanding of cancer and its interaction with the immune system, cancer immunotherapy, which trains or stimulates the body’s innate immune system to attack tumor cells, has made rapid progress and shows great promise as the next generation of cancer treatment strategies (Palucka & Banchereau, 2012 ; Liu et al., 2018 ). Accumulating evidence suggests that additional engagement of the immune response contributes significantly to the over antitumor efficacy of cancer therapy (Galluzzi et al., 2012 ; Yoon et al., 2018 ): for instance, certain chemotherapeutic agents (e.g., oxaliplatin and anthracyclines) and exogenous stimulus (e.g., photodynamic therapy) induce immunogenic cell death (ICD) in tumor cells (Huang et al., 2019 ; Zhang et al., 2021 ). Apoptosis has been considered as a procedural form of cell death with poor immunogenicity and physiology (Erwig & Henson, 2008 ; Tesniere et al., 2008; Green et al., 2009 ; Morioka et al., 2019 ).…”
Section: Introductionmentioning
confidence: 99%